Abbott India Ltd. (ABBOTINDIA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 919728, "name": "Abbott India", "stock_name": "Abbott India", "full_name": "Abbott India Ltd.", "name_url": "stocks-analysis/abbott-india", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "27,415.00", "chg": 135, "chgp": "0.49%", "dir": 1, "prev_price": "27,280.00", "mcapval": "58,254.96 Cr", "mcap": "Mid Cap", "scripcode": 500488, "symbol": "ABBOTINDIA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE358A01014", "curr_date": "May 14", "curr_time": "", "bse_nse_vol": "7.63 k", "exc_status": "Active", "traded_date": "May 14, 2026", "traded_date_str": "2026 05 14", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abbott-india-919728-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Abbott India Ltd. Downgraded to Sell Amid Valuation and Quality Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-downgraded-to-sell-amid-valuation-and-quality-concerns-3988870", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_mojoScore_3988870.png", "date": "2026-05-13 08:25:29", "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 12 May 2026. This shift reflects a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong long-term returns and robust management efficiency, the company faces challenges from stretched valuations and a mixed technical outlook, prompting a more cautious stance from analysts." }, { "title": "Abbott India Ltd: Quality Grade Downgrade Reflects Mixed Business Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-quality-grade-downgrade-reflects-mixed-business-fundamentals-3988355", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_qualitydot_3988355.png", "date": "2026-05-13 08:00:09", "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade downgraded from ‘Excellent’ to ‘Good’ by MarketsMOJO, accompanied by a shift in its Mojo Grade from Hold to Sell as of 12 May 2026. This change reflects a nuanced alteration in the company’s business fundamentals, with certain key metrics showing improvement while others indicate a deterioration in operational consistency and financial quality." }, { "title": "Are Abbott India Ltd. latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-abbott-india-ltd-latest-results-good-or-bad-3988026", "imagepath": "", "date": "2026-05-12 19:15:56", "description": "Abbott India Ltd.'s latest financial results for the quarter ending March 2026 reveal a mixed operational performance amidst a challenging pharmaceutical environment. The company reported net sales of ₹1,709.51 crores, reflecting a year-on-year growth of 6.54%, although this marked a sequential decline of 0.84% from the previous quarter. The net profit for the same quarter stood at ₹394.93 crores, which represents a year-on-year increase of 7.60% and a quarter-on-quarter growth of 5.05%. \n\nThe operating margin, excluding other income, improved to 28.13%, up 142 basis points from the corresponding quarter last year, indicating effective cost management. The profit after tax (PAT) margin also saw a slight increase to 23.10%, up from 22.87% in the prior year, showcasing the company's ability to maintain profitability despite inflationary pressures.\n\nFor the full fiscal year FY26, Abbott India achieved consolid..." }, { "title": "Abbott India Q4 FY26: Margin Resilience Masks Profit Volatility Amid Premium Valuation", "link": "https://www.marketsmojo.com/news/result-analysis/abbott-india-q4-fy26-margin-resilience-masks-profit-volatility-amid-premium-valuation-3987661", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndia_quaterlyResult_3987661.png", "date": "2026-05-12 11:48:14", "description": "Abbott India Ltd., one of the leading multinational pharmaceutical companies in India with operations spanning owned manufacturing facilities and third-party contractors, reported net profit of ₹394.93 crores for Q4 FY26 (quarter ending March 2026), representing a sequential increase of 5.05% from Q3 FY26's ₹375.96 crores and a year-on-year growth of 7.60% from ₹367.04 crores in Q4 FY25. With a market capitalisation of ₹57,361.75 crores, the stock traded at ₹26,994.65 on May 12, 2026, down 2.82% on the day, reflecting investor caution despite the company's resilient operating performance." }, { "title": "Abbott India Gains 4.86%: 3 Key Factors Driving This Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-gains-486-3-key-factors-driving-this-weeks-momentum-3983282", "imagepath": "", "date": "2026-05-09 14:06:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>4 May:</strong> Week opens at ₹25,426.70</p>\n <p><strong>6 May:</strong> Sharp 3.84% price jump to ₹26,295.50</p>\n <p><strong>7 May:</strong> Mojo Grade upgraded to Hold amid mixed technical and valuation signals</p>\n <p><strong>8 May:</strong> Week closes at ₹26,661.45, up 4.86% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.25,426.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.26,661.45</div><div class=\"st..." }, { "title": "Abbott India Ltd. Upgraded to Hold by MarketsMOJO Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-upgraded-to-hold-by-marketsmojo-amid-mixed-technical-and-valuation-signals-3979072", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_mojoScore_3979072.png", "date": "2026-05-07 08:21:43", "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 6 May 2026. This shift reflects nuanced changes across four critical parameters: quality, valuation, financial trend, and technicals. Despite a challenging recent performance, the company’s strong fundamentals and evolving market signals have prompted a reassessment of its outlook." }, { "title": "Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3978912", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_technicaldot_3978912.png", "date": "2026-05-07 08:05:24", "description": "Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This change accompanies a 3.84% gain in the stock price on 7 May 2026, reflecting renewed investor interest despite mixed signals from key technical indicators." }, { "title": "Abbott India Ltd: Valuation Shift Signals Price Attractiveness Change Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-valuation-shift-signals-price-attractiveness-change-amid-sector-dynamics-3978735", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_valuationdot_3978735.png", "date": "2026-05-07 08:01:45", "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This change reflects evolving market perceptions and raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks." }, { "title": "Abbott India Ltd. is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-by-marketsmojo-3973080", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_mojoScore_3973080.png", "date": "2026-05-04 10:10:44", "description": "Abbott India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 239, "sid": "919728", "stock_news_url": "https://www.marketsmojo.com/news/abbott-india-919728" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Abbott India Ltd. has declared <strong>4750%</strong> dividend, ex-date: 25 Jul 25", "dt": "2025-07-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

4 May: Week opens at ₹25,426.70

6 May: Sharp 3.84% price jump to ₹26,295.50

7 May: Mojo Grade upgraded to Hold amid mixed technical and valuation signals

8 May: Week closes at ₹26,661.45, up 4.86% for the week

Read full news article

Abbott India Ltd. Upgraded to Hold by MarketsMOJO Amid Mixed Technical and Valuation Signals

2026-05-07 08:21:43

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 6 May 2026. This shift reflects nuanced changes across four critical parameters: quality, valuation, financial trend, and technicals. Despite a challenging recent performance, the company’s strong fundamentals and evolving market signals have prompted a reassessment of its outlook.

Read full news article

Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-07 08:05:24

Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This change accompanies a 3.84% gain in the stock price on 7 May 2026, reflecting renewed investor interest despite mixed signals from key technical indicators.

Read full news article

Abbott India Ltd: Valuation Shift Signals Price Attractiveness Change Amid Sector Dynamics

2026-05-07 08:01:45

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This change reflects evolving market perceptions and raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks.

Read full news article

Abbott India Ltd. is Rated Sell by MarketsMOJO

2026-05-04 10:10:44

Abbott India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article